GENE AND CELL THERAPIES TARGETING CNS DISORDERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Market Segmentation

• Therapy Type Insights (Revenue, USD Bn, 2026 - 2033)

  • Gene Therapy
  • Cell Therapy

• Indication Insights (Revenue, USD Bn, 2026 - 2033)

  • Alzheimer's Disease (AD)
  • Huntington's Disease (HD)
  • Parkinson's Disease (PD)
  • Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease
  • Multiple Sclerosis (MS)
  • Adrenoleukodystrophy & Metachromatic Leukodystrophy
  • Neuropathies
  • Batten Disease (BD)

• Regional Insights (Revenue, USD Bn, 2026 - 2033)

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa